HEADER TRANSFERASE 03-JAN-18 6FEX TITLE DDR1, 2-[4-BROMO-2-OXO-1'-(1H-PYRAZOLO[4,3-B]PYRIDINE-5-CARBONYL) TITLE 2 SPIRO[INDOLE-3,4'-PIPERIDINE]-1-YL]-N-(2,2,2-TRIFLUOROETHYL) TITLE 3 ACETAMIDE, 1.291A, P212121, RFREE=17.4% COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: TYROSINE KINASE DOMAIN, RESIDUES 593-913; COMPND 5 SYNONYM: EPITHELIAL DISCOIDIN DOMAIN RECEPTOR 1,CD167 ANTIGEN-LIKE COMPND 6 FAMILY MEMBER A,CELL ADHESION KINASE,DISCOIDIN RECEPTOR TYROSINE COMPND 7 KINASE,HGK2,MAMMARY CARCINOMA KINASE 10,MCK-10,PROTEIN-TYROSINE COMPND 8 KINASE 3A,PROTEIN-TYROSINE KINASE RTK-6,TRK E,TYROSINE KINASE DDR, COMPND 9 TYROSINE-PROTEIN KINASE CAK; COMPND 10 EC: 2.7.10.1; COMPND 11 ENGINEERED: YES; COMPND 12 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS RTK, RECEPTOR TYROSINE KINASE, COLLAGEN, DISCOIDIN DOMAIN;, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.STIHLE,H.RICHTER,J.BENZ,B.KUHN,M.G.RUDOLPH REVDAT 4 01-MAY-24 6FEX 1 REMARK REVDAT 3 16-DEC-20 6FEX 1 SPRSDE REVDAT 2 27-MAR-19 6FEX 1 JRNL REVDAT 1 28-NOV-18 6FEX 0 SPRSDE 16-DEC-20 6FEX 6FIM JRNL AUTH H.RICHTER,A.L.SATZ,M.BEDOUCHA,B.BUETTELMANN,A.C.PETERSEN, JRNL AUTH 2 A.HARMEIER,R.HERMOSILLA,R.HOCHSTRASSER,D.BURGER,B.GSELL, JRNL AUTH 3 R.GASSER,S.HUBER,M.N.HUG,B.KOCER,B.KUHN,M.RITTER, JRNL AUTH 4 M.G.RUDOLPH,F.WEIBEL,J.MOLINA-DAVID,J.J.KIM,J.V.SANTOS, JRNL AUTH 5 M.STIHLE,G.J.GEORGES,R.D.BONFIL,R.FRIDMAN,S.UHLES,S.MOLL, JRNL AUTH 6 C.FAUL,A.FORNONI,M.PRUNOTTO JRNL TITL DNA-ENCODED LIBRARY-DERIVED DDR1 INHIBITOR PREVENTS FIBROSIS JRNL TITL 2 AND RENAL FUNCTION LOSS IN A GENETIC MOUSE MODEL OF ALPORT JRNL TITL 3 SYNDROME. JRNL REF ACS CHEM.BIOL. V. 14 37 2019 JRNL REFN ESSN 1554-8937 JRNL PMID 30452219 JRNL DOI 10.1021/ACSCHEMBIO.8B00866 REMARK 2 REMARK 2 RESOLUTION. 1.29 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.12RC1_2801 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.29 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 60.47 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 75.5 REMARK 3 NUMBER OF REFLECTIONS : 56910 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.139 REMARK 3 R VALUE (WORKING SET) : 0.137 REMARK 3 FREE R VALUE : 0.174 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 2839 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 60.5383 - 3.5044 0.99 3641 187 0.1494 0.1553 REMARK 3 2 3.5044 - 2.7815 0.99 3607 183 0.1359 0.1656 REMARK 3 3 2.7815 - 2.4299 0.99 3522 202 0.1263 0.1586 REMARK 3 4 2.4299 - 2.2078 0.99 3571 175 0.1170 0.1440 REMARK 3 5 2.2078 - 2.0495 0.98 3456 226 0.1133 0.1680 REMARK 3 6 2.0495 - 1.9287 0.98 3539 194 0.1149 0.1376 REMARK 3 7 1.9287 - 1.8321 0.98 3490 173 0.1177 0.1597 REMARK 3 8 1.8321 - 1.7523 0.98 3513 172 0.1189 0.1818 REMARK 3 9 1.7523 - 1.6848 0.97 3473 183 0.1313 0.1899 REMARK 3 10 1.6848 - 1.6267 0.97 3448 175 0.1332 0.2227 REMARK 3 11 1.6267 - 1.5758 0.97 3455 175 0.1473 0.2136 REMARK 3 12 1.5758 - 1.5308 0.94 3400 171 0.1733 0.2513 REMARK 3 13 1.5308 - 1.4905 0.85 3026 148 0.1876 0.2336 REMARK 3 14 1.4905 - 1.4541 0.75 2682 148 0.1983 0.2579 REMARK 3 15 1.4541 - 1.4211 0.66 2357 125 0.2123 0.2958 REMARK 3 16 1.4211 - 1.3908 0.47 1677 88 0.2178 0.2489 REMARK 3 17 1.3908 - 1.3630 0.33 1161 65 0.2255 0.2863 REMARK 3 18 1.3630 - 1.3373 0.18 655 36 0.2099 0.3234 REMARK 3 19 1.3373 - 1.3134 0.08 281 8 0.2076 0.4557 REMARK 3 20 1.3134 - 1.2911 0.03 117 5 0.2492 0.3564 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.130 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.490 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.05 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 2504 REMARK 3 ANGLE : 1.101 3403 REMARK 3 CHIRALITY : 0.082 358 REMARK 3 PLANARITY : 0.007 440 REMARK 3 DIHEDRAL : 18.484 988 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BROMINE PARTIALLY RADIOLYZED. ANOMALOUS REMARK 3 PEAK CA 10A NEXT TO BROMINE COULD IN PRINCIPLE ALSO BE BROMINE REMARK 3 ATOM, BUT SINCE IODIDE WAS PRESENT IN THE MOTHER LIQUOR, NO REMARK 3 DECISION CAN BE MADE BASED ON DENSITIES. REMARK 4 REMARK 4 6FEX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-JAN-18. REMARK 100 THE DEPOSITION ID IS D_1200008187. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-JUL-17 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99999 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE, XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 67043 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.330 REMARK 200 RESOLUTION RANGE LOW (A) : 61.750 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 3.710 REMARK 200 R MERGE (I) : 0.07100 REMARK 200 R SYM (I) : 0.07100 REMARK 200 FOR THE DATA SET : 8.3500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.33 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.46 REMARK 200 R MERGE FOR SHELL (I) : 0.74700 REMARK 200 R SYM FOR SHELL (I) : 0.74700 REMARK 200 FOR SHELL : 1.050 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: INHOUSE MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 11.3 MG/ML PROTEIN IN 20MM HEPES/NAOH REMARK 280 PH7.5, 5MM DTT, 5% GLYCEROL, 0.1M NACL MIXED 1.3:1 WITH 90MM MES/ REMARK 280 NAOH PH6.5, 0.18M POTASSIUM IODIDE, 0.2M LI2SO4, 22.5% PEG 4K, REMARK 280 PH 5.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.87500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1550 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14600 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -36.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 593 REMARK 465 GLY A 594 REMARK 465 ALA A 595 REMARK 465 VAL A 596 REMARK 465 GLY A 597 REMARK 465 ASP A 598 REMARK 465 GLY A 599 REMARK 465 PRO A 600 REMARK 465 PRO A 601 REMARK 465 SER A 637 REMARK 465 LEU A 638 REMARK 465 ASP A 639 REMARK 465 LYS A 727 REMARK 465 ALA A 728 REMARK 465 ALA A 729 REMARK 465 GLU A 730 REMARK 465 GLY A 731 REMARK 465 ALA A 732 REMARK 465 PRO A 733 REMARK 465 GLY A 734 REMARK 465 ASP A 735 REMARK 465 ALA A 909 REMARK 465 LEU A 910 REMARK 465 ASN A 911 REMARK 465 THR A 912 REMARK 465 VAL A 913 REMARK 465 HIS A 914 REMARK 465 HIS A 915 REMARK 465 HIS A 916 REMARK 465 HIS A 917 REMARK 465 HIS A 918 REMARK 465 HIS A 919 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1282 O HOH A 1374 2.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 HD21 ASN A 667 H TYR A 869 2444 1.34 REMARK 500 O HOH A 1371 O HOH A 1432 1655 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 698 CB CYS A 698 SG -0.134 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 698 CA - CB - SG ANGL. DEV. = 6.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 765 -14.46 82.04 REMARK 500 ASP A 766 43.87 -143.57 REMARK 500 ALA A 783 -167.33 -128.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue D6Z A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IOD A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IOD A 1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IOD A 1004 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IOD A 1005 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MES A 1006 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 1007 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 1008 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 1009 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 1010 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6FER RELATED DB: PDB REMARK 900 RELATED ID: 6FEW RELATED DB: PDB DBREF 6FEX A 593 913 UNP Q08345 DDR1_HUMAN 574 894 SEQADV 6FEX A UNP Q08345 GLY 711 DELETION SEQADV 6FEX A UNP Q08345 GLN 712 DELETION SEQADV 6FEX A UNP Q08345 ALA 713 DELETION SEQADV 6FEX A UNP Q08345 ALA 714 DELETION SEQADV 6FEX A UNP Q08345 GLN 715 DELETION SEQADV 6FEX A UNP Q08345 GLY 716 DELETION SEQADV 6FEX HIS A 914 UNP Q08345 EXPRESSION TAG SEQADV 6FEX HIS A 915 UNP Q08345 EXPRESSION TAG SEQADV 6FEX HIS A 916 UNP Q08345 EXPRESSION TAG SEQADV 6FEX HIS A 917 UNP Q08345 EXPRESSION TAG SEQADV 6FEX HIS A 918 UNP Q08345 EXPRESSION TAG SEQADV 6FEX HIS A 919 UNP Q08345 EXPRESSION TAG SEQRES 1 A 321 PRO GLY ALA VAL GLY ASP GLY PRO PRO ARG VAL ASP PHE SEQRES 2 A 321 PRO ARG SER ARG LEU ARG PHE LYS GLU LYS LEU GLY GLU SEQRES 3 A 321 GLY GLN PHE GLY GLU VAL HIS LEU CYS GLU VAL ASP SER SEQRES 4 A 321 PRO GLN ASP LEU VAL SER LEU ASP PHE PRO LEU ASN VAL SEQRES 5 A 321 ARG LYS GLY HIS PRO LEU LEU VAL ALA VAL LYS ILE LEU SEQRES 6 A 321 ARG PRO ASP ALA THR LYS ASN ALA ARG ASN ASP PHE LEU SEQRES 7 A 321 LYS GLU VAL LYS ILE MET SER ARG LEU LYS ASP PRO ASN SEQRES 8 A 321 ILE ILE ARG LEU LEU GLY VAL CYS VAL GLN ASP ASP PRO SEQRES 9 A 321 LEU CYS MET ILE THR ASP TYR MET GLU ASN GLY ASP LEU SEQRES 10 A 321 ASN GLN PHE LEU SER ALA HIS GLN LEU GLU ASP LYS ALA SEQRES 11 A 321 ALA GLU GLY ALA PRO GLY ASP PRO THR ILE SER TYR PRO SEQRES 12 A 321 MET LEU LEU HIS VAL ALA ALA GLN ILE ALA SER GLY MET SEQRES 13 A 321 ARG TYR LEU ALA THR LEU ASN PHE VAL HIS ARG ASP LEU SEQRES 14 A 321 ALA THR ARG ASN CYS LEU VAL GLY GLU ASN PHE THR ILE SEQRES 15 A 321 LYS ILE ALA ASP PHE GLY MET SER ARG ASN LEU TYR ALA SEQRES 16 A 321 GLY ASP TYR TYR ARG VAL GLN GLY ARG ALA VAL LEU PRO SEQRES 17 A 321 ILE ARG TRP MET ALA TRP GLU CYS ILE LEU MET GLY LYS SEQRES 18 A 321 PHE THR THR ALA SER ASP VAL TRP ALA PHE GLY VAL THR SEQRES 19 A 321 LEU TRP GLU VAL LEU MET LEU CYS ARG ALA GLN PRO PHE SEQRES 20 A 321 GLY GLN LEU THR ASP GLU GLN VAL ILE GLU ASN ALA GLY SEQRES 21 A 321 GLU PHE PHE ARG ASP GLN GLY ARG GLN VAL TYR LEU SER SEQRES 22 A 321 ARG PRO PRO ALA CYS PRO GLN GLY LEU TYR GLU LEU MET SEQRES 23 A 321 LEU ARG CYS TRP SER ARG GLU SER GLU GLN ARG PRO PRO SEQRES 24 A 321 PHE SER GLN LEU HIS ARG PHE LEU ALA GLU ASP ALA LEU SEQRES 25 A 321 ASN THR VAL HIS HIS HIS HIS HIS HIS HET D6Z A1001 56 HET IOD A1002 1 HET IOD A1003 1 HET IOD A1004 1 HET IOD A1005 1 HET MES A1006 25 HET CL A1007 1 HET CL A1008 1 HET CL A1009 1 HET CL A1010 1 HETNAM D6Z 2-[4-BROMANYL-2-OXIDANYLIDENE-1'-(1~{H}-PYRAZOLO[4,3- HETNAM 2 D6Z B]PYRIDIN-5-YLCARBONYL)SPIRO[INDOLE-3,4'-PIPERIDINE]- HETNAM 3 D6Z 1-YL]-~{N}-[2,2,2-TRIS(FLUORANYL)ETHYL]ETHANAMIDE HETNAM IOD IODIDE ION HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETNAM CL CHLORIDE ION FORMUL 2 D6Z C23 H20 BR F3 N6 O3 FORMUL 3 IOD 4(I 1-) FORMUL 7 MES C6 H13 N O4 S FORMUL 8 CL 4(CL 1-) FORMUL 12 HOH *336(H2 O) HELIX 1 AA1 PRO A 606 SER A 608 5 3 HELIX 2 AA2 SER A 631 LEU A 635 5 5 HELIX 3 AA3 THR A 662 SER A 677 1 16 HELIX 4 AA4 ASP A 708 ALA A 715 1 8 HELIX 5 AA5 SER A 739 LEU A 760 1 22 HELIX 6 AA6 ALA A 768 ARG A 770 5 3 HELIX 7 AA7 GLU A 776 PHE A 778 5 3 HELIX 8 AA8 ARG A 789 TYR A 796 5 8 HELIX 9 AA9 PRO A 806 MET A 810 5 5 HELIX 10 AB1 ALA A 811 GLY A 818 1 8 HELIX 11 AB2 THR A 821 MET A 838 1 18 HELIX 12 AB3 THR A 849 ASP A 863 1 15 HELIX 13 AB4 PRO A 877 TRP A 888 1 12 HELIX 14 AB5 GLU A 891 ARG A 895 5 5 HELIX 15 AB6 PRO A 897 ASP A 908 1 12 SHEET 1 AA1 5 LEU A 610 GLU A 618 0 SHEET 2 AA1 5 GLY A 622 VAL A 629 -1 O GLU A 628 N ARG A 611 SHEET 3 AA1 5 LEU A 651 LEU A 657 -1 O ILE A 656 N GLU A 623 SHEET 4 AA1 5 CYS A 698 ASP A 702 -1 O MET A 699 N LYS A 655 SHEET 5 AA1 5 LEU A 687 CYS A 691 -1 N LEU A 688 O ILE A 700 SHEET 1 AA2 2 GLN A 717 LEU A 718 0 SHEET 2 AA2 2 THR A 737 ILE A 738 1 O ILE A 738 N GLN A 717 SHEET 1 AA3 2 CYS A 772 VAL A 774 0 SHEET 2 AA3 2 ILE A 780 ILE A 782 -1 O LYS A 781 N LEU A 773 CISPEP 1 ASP A 695 PRO A 696 0 -2.41 SITE 1 AC1 16 VAL A 624 ALA A 653 GLU A 672 MET A 676 SITE 2 AC1 16 ILE A 685 THR A 701 TYR A 703 MET A 704 SITE 3 AC1 16 HIS A 764 LEU A 773 ALA A 783 ASP A 784 SITE 4 AC1 16 PHE A 785 HOH A1214 HOH A1274 HOH A1323 SITE 1 AC2 1 ARG A 886 SITE 1 AC3 1 HOH A1361 SITE 1 AC4 1 ARG A 658 SITE 1 AC5 1 MES A1006 SITE 1 AC6 10 TRP A 834 MET A 838 ALA A 842 GLN A 843 SITE 2 AC6 10 PHE A 845 GLY A 846 LEU A 870 SER A 871 SITE 3 AC6 10 IOD A1005 HOH A1113 SITE 1 AC7 1 SER A 739 SITE 1 AC8 4 ASP A 681 PRO A 682 ARG A 686 HOH A1188 SITE 1 AC9 1 CYS A 698 SITE 1 AD1 3 GLN A 717 LEU A 718 HOH A1378 CRYST1 40.834 61.750 63.072 90.00 106.51 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024489 0.000000 0.007258 0.00000 SCALE2 0.000000 0.016194 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016537 0.00000